Illumina shares react negatively after Q3 earnings
FROM THE WIRE · FINANCE.YAHOO.COM
The top 5 analyst questions from Illumina's Q3 earnings call Illumina's third quarter was met with a negative market reaction. Management attributed the quarter's performance to strong clinical sequencing demand and robust placements of the NovaSeq X platform, which CEO Jacob…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishResults beat estimates slightly but weakness in research markets drove a negative share reaction.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue of 1.17 billion dollars versus 1.15 billion expected by analysts.
- 02Adjusted EPS was 1.44 dollars against 1.36 estimated.
- 03Management flagged continued weakness in research and applied markets.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Illumina, Inc.229.38 USD-1.57%today -2.80%Negative Illumina Inc208.16 EURMarket closedtoday -1.08%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets